Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Arcus Biosciences, Inc.
Universidade Federal de Pernambuco
Shenzhen BinDeBio Ltd.
Ohio State University Comprehensive Cancer Center
Shenzhen Second People's Hospital
Celldex Therapeutics
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Case Comprehensive Cancer Center